Although these elegant studies proposed pathogenic mechanisms for anti-AT1R in kidney transplant and systemic sclerosis patients, to the best of our knowledge no experimental evidence exists demonstrating pathogenic functions of anti-AT1R in the context of LTx and PGD onset. This evidence concerns the gene AGTR1 and systemic sclerosis.